Universe Pharmaceuticals ... (UPC)
NASDAQ: UPC
· Real-Time Price · USD
3.54
-0.02 (-0.56%)
At close: Aug 15, 2025, 12:12 PM
Universe Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 |
Revenue | 9.15M | 10.14M | 12.88M | 13.84M | 18.47M | 15.94M | 24.2M | 23.69M | 24.29M |
Cost of Revenue | 5.99M | 7.31M | 9.64M | 9.78M | 12.45M | 7.89M | 10.57M | 10.42M | 12.42M |
Gross Profit | 3.16M | 2.83M | 3.24M | 4.06M | 6.01M | 8.05M | 13.63M | 13.26M | 11.87M |
Operating Income | -2.33M | -6.28M | -1.74M | -3.68M | 149.25K | -10.14M | 2.7M | 4.01M | 9.58M |
Interest Income | n/a | n/a | n/a | n/a | 166.93K | n/a | 696.43K | 239.55K | n/a |
Pretax Income | -3.28M | 4.32M | -12.44M | -4.14M | 258.93K | -11.33M | 3.31M | 4.12M | 9.53M |
Net Income | -3.28M | 4.37M | -13.1M | -5.45M | -715.43K | -10.47M | 1.73M | 4.17M | 7.15M |
Selling & General & Admin | 5.39M | 5.59M | 4.85M | 5.06M | 3.55M | -18.58M | 10.72M | 4.17M | 1.91M |
Research & Development | 96.84K | 2.96M | 86.5K | 2.61M | 2.29M | 7.49M | 134.46K | 5.03M | 320.55K |
Other Expenses | n/a | 558.67K | 45.8K | 68.79K | 26.8K | 29.07M | 77.24K | 246.05K | 57.99K |
Operating Expenses | 5.49M | 9.11M | 4.98M | 7.74M | 5.87M | 17.98M | 10.93M | 9.45M | 2.29M |
Interest Expense | 128.75K | 141.56K | 136.61K | 82.22K | 74.57K | 74.01K | 88.39K | 54.93K | 46.67K |
Selling & Marketing Expenses | n/a | 7.26M | n/a | n/a | n/a | -20.25M | 38.55M | 1.81M | 1.17M |
Cost & Expenses | 11.48M | 16.42M | 14.62M | 17.52M | 18.32M | 25.66M | 21.5M | 19.68M | 14.71M |
Income Tax Expense | n/a | -58.44K | 665.15K | 1.34M | 974.36K | -825.8K | 1.58M | -52.22K | 2.41M |
Shares Outstanding (Basic) | 3.48K | 6.08K | 6.08K | 5.92K | 5.92K | 5.92K | 5.92K | 5.27K | 5.27K |
Shares Outstanding (Diluted) | 3.48K | 6.08K | 6.08K | 5.92K | 5.92K | 5.92K | 5.92K | 5.27K | 5.27K |
EPS (Basic) | -944.4 | 719.79 | -2.16K | -919.74 | -120.79 | -1.77K | 292.37 | 791.38 | 1.36K |
EPS (Diluted) | -944.4 | 719.79 | -2.16K | -919.74 | -120.79 | -1.77K | 292.37 | 791.38 | 1.36K |
EBITDA | -2.89M | 4.69M | -12.05M | -3.81M | 591.28K | -11.02M | 3.69M | 4.38M | 9.82M |
EBIT | -3.16M | 4.46M | -12.3M | -4.06M | 333.5K | -11.26M | 3.4M | 4.17M | 9.57M |
Depreciation & Amortization | 269.64K | 236.87K | 248.86K | 251K | 257.78K | 241.84K | 292.11K | 203.41K | 243.47K |